Transcriptional regulation of the target genes of transforming growth factor-β and it's abnormalities in disease.
Transcriptional regulation of the target genes of transforming growth factor-β and it's abnormalities in disease.
批准号:
14570208
负责人:
KATO Mitsuyasu
金额:
$2.62万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have identified a TIE/E2F element that is critical for transcriptional regulation of c-myc in both serum-induced induction and TGF-β-induced suppression. Another element TBE3 that is activated by WNT signaling is also identified in the transcriptional regulatory region of c-myc. TGF-β-activated Smad3 binds a TIE/E2F element and dissociates p300 from E2F-4. On TBE3, TCF-4 releases β-catenin when binds Smad3. However, LEF-1 can bind both β-catenin and Smad3 at the same time. Therefore, transcriptional activity of c-myc activated by β-catenin is blocked by TGF-β in the presence of TCF-4 but it is resistant in the presence of LEE-1. These results suggested that enhanced, LEF-1 expression frequently observed in colon cancer might cancel TGF-β-induced repression of c-myc.Smad2D450E mutant was previously identified in colon caner. TGF-β signaling could not phosphorylate this mutant. We have shown that Smad2D450E can block phosphorylation of co-expressed wild-type Smad2 but not of Smad3, and that binding of Smad3 and Smad4 was not blocked by Smad2D450E either. However, Smad2D450E blocked the binding of Smad3 to it's target DNA and suppressed Smad3-responsive gene expression. Therefore, Smad2D450E is suggested to block Smad3 function either in the step of nuclear translocation or in the nucleus.We have examined the effects of c-Ski on the transcriptional repression of c-myc by TGF-β. c-Ski recovered transcriptional activity of c-myc suppressed by TGF-β. This function of c-Ski is not explained by known molecular function of c-Ski. We propose the novel role of c-Ski. c-Ski is suggested to compete the binding of an active Smad complex on their target DNA by extending the binding of an inactive Smad-c-Ski complex on the target DNA.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
加藤 光保: "トランスフォーミング増殖因子βによる転写制御"蛋白質核酸酵素. 48. 2247-2253 (2003)
Mitsuyasu Kato:“通过转化生长因子 β 进行转录控制”蛋白质核酸酶。 48. 2247-2253 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kato M.: "Transcriptional regulation by the transforming growth factor-β signaling (Japanese)"Protein, Nucleic Acid and Enzyme. 48. 2247-2253 (2003)
Kato M.:“转化生长因子-β 信号传导的转录调节(日语)”蛋白质、核酸和酶 48. 2247-2253 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K.: "c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad binding elements."Oncogene. (in press). (2004)
Suzuki H、Yagi K、Kondo M、Kato M、Miyazono K、Miyazawa K.:“c-Ski 通过稳定 Smad 结合元件上的非活性 Smad 复合物来抑制 TGF-β 信号通路。”Oncogene(出版中)。 )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki H et al.: "c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad binding elements"Oncogene. (in press).
Suzuki H 等人:“c-Ski 通过稳定 Smad 结合元件上的非活性 Smad 复合物来抑制 TGF-β 信号传导途径”Oncogene(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kondo M, Suzuki H, Takehara K, Miyazono K, Kato M.: "Transforming growth factor-β signaling is differentially inhibited by Smad2D450E and Smad3D407E."Cancer Sci.. 95. 12-17 (2004)
Kondo M、Suzuki H、Takehara K、Miyazono K、Kato M.:“Smad2D450E 和 Smad3D407E 不同地抑制转化生长因子-β 信号传导。”Cancer Sci.. 95. 12-17 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Induction of Cancer Stem Cell Properties by GPNMB
-
批准号:18H02676
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2018
-
负责人:KATO Mitsuyasu
-
依托单位:
Tumorigenic activity of tissue-specific oncogene THG-1
-
批准号:25640059
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2013
-
负责人:KATO Mitsuyasu
-
依托单位:
Translational TGF-β Research for Diagnosis, Treatment, and Prevention of Cancer
-
批准号:21390115
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2009
-
负责人:KATO Mitsuyasu
-
依托单位:
Growth inhibition of keratinocytes by TGF-β and the impaired signaling in cancer cells
-
批准号:11670232
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:KATO Mitsuyasu
-
依托单位:
Autocrine growth inhibitors of keratinocytes and their significance in carcinogenesis
-
批准号:09670243
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1997
-
负责人:KATO Mitsuyasu
-
依托单位:
Responsible proteins and genes for the development of intractable vasculitis
-
批准号:07457583
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.77万
-
财政年份:1995
-
负责人:KATO Mitsuyasu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于BMP2/Smad1/Runx2通路调控干细胞成骨分化及桃红四物汤促进骨折愈合的研究
-
批准号:2026JJ80308
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺渊哲
-
依托单位:
基于菌群时间节律驱动GLU及BMP2/SMAD1诱导多能干细胞探讨太极拳改善老年慢性疼痛机制研究
-
批准号:2026JJ70009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张峰
-
依托单位:
LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
-
批准号:2026JJ82108
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭亮
-
依托单位:
LINC00472通过miR-21-5p调节GLIS2和SMAD7的表达在胆道闭锁肝纤维化的作用及机制研究
-
批准号:2026JJ82157
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:许光
-
依托单位:
新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
-
批准号:ZCLQN26H2604
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王言
-
依托单位:
tRF-1:32-Glu-TTC-2-M2通过Smad3参与特发性肺动脉高压右心纤维化的机制研究
-
批准号:2026JJ81725
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐毅
-
依托单位:
西达本胺通过调控SMAD7抑制EMT缓解二氧化硅诱导的肺纤维化的机制研究
-
批准号:JCZRLH202600206
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
-
批准号:JCZRLH202601800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于 hUC-MSCs外泌体miR-455-5p/TRIM33/Smad轴调控子宫内膜自噬修复宫腔粘连的机制研究
-
批准号:JCZRLH202600971
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
独活寄生汤靶向调控TGF-β1/Smad信号通路介导间充质干细胞成软骨分化治疗KOA的作用机制研究
-
批准号:2026JJ80282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段建辉
-
依托单位: